EPI Stock UPDATES India Earnings Wisdomtree (EPI) 23.21 11/02/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
India Earnings Wisdomtree (EPI) 23.21 $EPI

Sparkling India ETFs to Light Up Your Portfolio - ETF News And Commentary
Sweta Killa - ZACKS - Wed Oct 22, 1:00PM CDT
These funds could be great choice for investors seeking to maximize their returns on the auspicious occasion of Diwali.
SPY: 201.66 (+2.28), SMIN: 33.49 (+0.39), EPI: 23.21 (+0.37), GMF: 86.40 (+1.07), VWO: 42.64 (+0.34), INCO: 32.01 (+0.16)

3 Emerging Market ETFs to Buy On the Dip - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 9:00AM CDT
These emerging market ETFs could be interesting picks after the recent slump.
EEM: 42.15 (+0.18), EPI: 23.21 (+0.37), EPHE: 38.28 (+0.20), BBRC: 22.10 (+0.04)

ORBC, ESSA, OREX, DRR, EPI, EUO Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Thu Oct 09, 6:53AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ORBCOMM Inc (NASDAQ:ORBC), ESSA Bancorp Inc (NASDAQ:ESSA), Orexigen Therapeutics Inc (NASDAQ:OREX), MARKET VECTORS DBL SHORT EUR (NYSE RR), WisdomTree India Earnings Fund (NYSE:EPI), Eurocontrol Technics Group Inc (NYSE:EUO) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
OREX: 4.06 (-0.07), EPI: 23.21 (+0.37), ORBC: 6.32 (+0.16), ESSA: 11.49 (+0.02), EUO: 20.25 (+0.26), DRR: 46.44 (+0.66)

Watch for WisdomTree India Earnings Fund to Potentially Pullback After Gaining 2.27% Yesterday
Comtex SmarTrend(R) - Wed Oct 08, 4:39PM CDT
WisdomTree India Earnings Fund (NYSE:EPI) traded in a range yesterday that spanned from a low of $21.58 to a high of $22.16. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $22.14 on volume of 8.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EPI: 23.21 (+0.37)

WisdomTree India Earnings Fund Set to Possibly Rebound After Yesterday's Selloff of 1.27%
Comtex SmarTrend(R) - Tue Sep 16, 5:03PM CDT
WisdomTree India Earnings Fund (NYSE:EPI) traded in a range yesterday that spanned from a low of $22.24 to a high of $22.61. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $22.76 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EPI: 23.21 (+0.37)

MELI, ATHN, EPI, IPCM, IRY, WAL Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Sep 12, 5:24AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of MercadoLibre Inc (NASDAQ:MELI), Athenahealth Inc (NASDAQ:ATHN), WisdomTree India Earnings Fund (NYSE:EPI), IPC The Hospitalist Co Inc (NASDAQ:IPCM), Spdr S&P International Health Care Sector Etf (NYSE:IRY), Western Alliance Bancorporation (NYSE:WAL) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
WAL: 26.62 (+0.53), IPCM: 41.66 (+0.02), EPI: 23.21 (+0.37), MELI: 136.15 (+20.95), IRY: 48.36 (+0.41), ATHN: 122.50 (+2.16)

After Yesterday's Decline of 1.32%, WisdomTree India Earnings Fund Offers Investors Better Value
Comtex SmarTrend(R) - Tue Sep 09, 4:49PM CDT
WisdomTree India Earnings Fund (NYSE:EPI) traded in a range yesterday that spanned from a low of $23.13 to a high of $23.36. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $23.16 on volume of 4.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EPI: 23.21 (+0.37)

The Zacks Analyst Blog Highlights: EGShares India Small Cap ETF, VanEck India Small Cap Index ETF, WisdomTree India Earnings Fund, Medtronic and Covidien
PR Newswire - Mon Sep 08, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the EGShares India Small Cap ETF (AMEX:SCIN-Free Report), VanEck India Small Cap Index ETF (AMEX:SCIF-Free Report), WisdomTree India Earnings Fund (AMEX:EPI-Free Report), Medtronic, Inc. (NYSE:MDT-Free Report) and Covidien plc (NYSE:COV-Free Report).
MDT: 68.16 (+0.73), EPI: 23.21 (+0.37)

WisdomTree India Earnings Fund Rises 1.38% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Sep 05, 4:25PM CDT
WisdomTree India Earnings Fund (NYSE:EPI) traded in a range yesterday that spanned from a low of $23.32 to a high of $23.57. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $23.42 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EPI: 23.21 (+0.37)

India ETFs: Best of the BRICs Now? - ETF News And Commentary
Neena Mishra - ZACKS - Fri Sep 05, 11:21AM CDT
Even after an excellent run this year, Indian stocks look attractive considering earnings growth prospects.
INDY: 31.42 (+0.58), SCIN: 16.96 (+0.32), EPI: 23.21 (+0.37), INDA: 31.89 (+0.60), SCIF: 46.62 (+0.94)

India ETFs: Best of BRICs Now? - ETF News And Commentary
Neena Mishra - ZACKS - Fri Sep 05, 11:21AM CDT
Even after an excellent run this year, Indian stocks look attractive considering earnings growth prospects.
INDY: 31.42 (+0.58), SCIN: 16.96 (+0.32), EPI: 23.21 (+0.37), INDA: 31.89 (+0.60), SCIF: 46.62 (+0.94)

India Is Still Surging
at The Street - Fri Sep 05, 11:08AM CDT
I haven't written a full column about India and investment performance and opportunities there since Narendra Modi and the Bharatiya Janata Party (BJP) won a commanding victory last May.
EPI: 23.21 (+0.37), INFY: 66.86 (+1.62), TTM: 47.10 (+1.34)

Shares of EPI Up 25.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Aug 07, 11:10AM CDT
SmarTrend identified an Uptrend for WisdomTree India Earnings Fund (NYSE:EPI) on March 5th, 2014 at $17.32. In approximately 5 months, WisdomTree India Earnings Fund has returned 25.67% as of today's recent price of $21.76.
EPI: 23.21 (+0.37)

Uptrend Call Working As WisdomTree India Earnings Fund Stock Rises 26.5% (EPI)
Comtex SmarTrend(R) - Thu Jul 31, 9:55AM CDT
SmarTrend identified an Uptrend for WisdomTree India Earnings Fund (NYSE:EPI) on March 5th, 2014 at $17.32. In approximately 5 months, WisdomTree India Earnings Fund has returned 26.54% as of today's recent price of $21.91.
EPI: 23.21 (+0.37)

31.2% Return Seen to Date on SmarTrend WisdomTree India Earnings Fund Call (EPI)
Comtex SmarTrend(R) - Thu Jul 24, 9:15AM CDT
SmarTrend identified an Uptrend for WisdomTree India Earnings Fund (NYSE:EPI) on March 5th, 2014 at $17.32. In approximately 5 months, WisdomTree India Earnings Fund has returned 31.19% as of today's recent price of $22.72.
EPI: 23.21 (+0.37)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vylor's $3 Billion Buyback: A Long-Term Bet

Updated Category News Views 7

Pumping Confidence with a Massive Buyback Vylor's big move to throw $3 billion into a share buyback isn't about short-term antics. This company's doubling down on long-term value creation, making sure every stakeholder knows they're in for the long haul. It's a gutsy move but what this step really tells us is, they've got faith in the business and a balance sheet that can...

Continue Reading
Anavex Faces Securities Lawsuit: Investor Implications

Updated Category News Views 0

Storm Clouds Over Anavex: What Investors Need to Know If you've got a slice of Anavex Life Sciences Corp. (NASDAQ: AVXL) in your portfolio, the latest chapter of their legal saga feels less like a twist and more like a twist of the knife. These lawsuits often come out of left field for investors, but this one seems like a slow train that’s been gathering steam for a...

Continue Reading
Tigo Energy Faces Class Action Over Revenue Claims

Updated Category News Views 4

Trouble Brewing for Tigo Energy? Straight from the horse's mouth, we hear about Tigo Energy (NASDAQ: TYGO) getting embroiled in a class action smackdown. Picture it: Tigo fumbles their projections, and boy does it sting. They're caught in the crossfire for allegedly puffing up their revenue expectations tied to a venture with EG4 Electronics—poised to churn out...

Continue Reading
WOLFX Super App Surges with 300% Growth Post-Launch

Updated Category News Views 4

A Fast-Paced Entry into the College Scene College life isn’t getting any easier, but the WOLFX app is blazing a trail through U.S. campuses, promising to mend some of the chaos students deal with daily. It's barely taken a breath since launching just a month ago, already knitting itself into the routine of students from 104 universities in 130 cities across America -...

Continue Reading
FuelCell's Class Action: Investors' Deadline Approaching

Updated Category News Views 3

One Rough Ride for FuelCell Investors Sometimes the market feels like a roller coaster stuck on the down-hill plunge, and right now, FuelCell Energy (NASDAQ: FCEL) investors are gripping their harnesses. The latest turmoil has investors looking at a tight November 10 deadline to decide if they want in on the securities class action shaking the ground beneath FCEL. Looming...

Continue Reading
Beyond The Bounce Expands with Pro Pickleball Star

Updated Category News Views 1

Pickleball's Power Play: The Media Move Out of the blue, the world of niche sports finds its hub. Beyond The Bounce steps up to the plate by roping in pickleball’s own Zane Navratil. The hype’s not in the spin here—this is serious business. The company plans to push the boundaries of the sport into mainstream media, or at least give it a decent shot. Zane Navratil:...

Continue Reading
HSG's Laser Tech Dazzles at FABTECH 2026

Updated Category News Views 1

Laser Innovations on Display at FABTECH 2026 Listen up, folks—FABTECH 2026 in Vegas is where HSG Laser decided to flaunt their new toys, codenamed TS2 PRO and the mystical AI CutPilot. Now, unless you've been living under a rock, you'll know HSG is all about shaking up the laser cutting scene. They've done it for two decades, and now they're pushing the envelope with...

Continue Reading
Volvo's Q3 2026 Results: Strong Growth and Margin

Updated Category News Views 4

Volvo Group's Robust Q3 Performance It's not every day that you see a company like Volvo Group churning out results that make you take a second sip of that morning coffee. But here we are—looking at Q3 2026 with growth numbers that pack a punch. You can't argue with SEK 119.5 billion in net sales, especially when organic sales growth hit 7%. That's no small feat in...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 6

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
3Srobotics Breaks Ground with North American Debut

Updated Category News Views 2

3Srobotics Steps Into the Big League The sweltering buzz of FABTECH 2026 in Las Vegas signals more than just another industry tradeshow; it's the stage upon which 3Srobotics made its North American debut. In a span shorter than it takes most companies to get serious about their business cards, 3Srobotics has already nailed three funding rounds, snagging tens of millions...

Continue Reading
class="blog__more"> More News Articles